Shanghai, 26 August 2022 – Fosun International Limited (“Fosun International”, stock code: 00656.HK) and HSBC Bank (China) Company Limited (“HSBC China”) renewed a strategic cooperation agreement (the “Agreement”) today to provide strong support for Fosun International and its subsidiaries (“Fosun”) in the aspects of global operation and investment capab

On August 23, the 2022 Fortune China ESG Impact List was announced, with 40 companies on the list.Fosun Pharma topped the list for its remarkable achievements in environmental, social, and corporate governance (ESG) and positive contributions in the fight against the COVID-19 pandemic.The 2022 Fortune China ESG Impact List was produced by the editorial team of

(23August2022) An analyst who is a key opinion leader (KOL) has made an analysis on Bloomberg terminal about Fosun International afterMoody’shas releaseda ratingreportabout the company. The following is the article extracted from the Bloomberg terminal post:The rating agency Moody’s just issued a report today and adjusted the corporate family rating of Fosun International(0656.HK) toB1

On 11 August, Guo Guangchang, Chairman of Fosun International, and his delegation met Zheng Zeguang, Chinese Ambassador to the United Kingdom (UK), at the Chinese Embassy in the UK in London. Bao Ling, Minister for Economic & Commercial Affairs of the Chinese Embassy in the UK, and Fosun's global partners, Li Haifeng, Shi Yu and others attended the meeting.

(25 July 2022) - Shanghai Henlius Biotech, Inc. (2696.HK) announced that the company’s business partner Cipla Limited (“Cipla”) has received the relevant registration certificates from the Therapeutic Goods Administration of Australia (“TGA”) for the approval of Henlius’ self-developed and manufactured HANQUYOU (trastuzumab, trade name in Europe: Zercepac^®) with the specification of 150mg/vial in Australia under the trade names Tuzucip^® and Trastucip^®, covering all indications of the reference trastuzumab approved in Australia. At present, Henlius is working with Cipla in Australia and this approval will help both parties bring HANQUYOU to more patients in Australia.

(26 July 2022) The 2nd China International Consumer Products Expo (CICPE) officially openstoday. More than 1,000 companies and a number of leading brands from 61 countries and regions around the world gathered together at theCICPEin Hainan, China. For the second year, Fosunhas invited its15 world-renowned brands anda number ofChinese time-honored brands to the internationaland domesticexhibition areas respectively, showcasing the latest products and services in the field of fashion, jewelry, cosmetics,culture andtourism, China-Chic, etc. It has attracted the attention of both domestic and international professional buyers on the first day of the expo.

(19 July, 2022, Shanghai, China) On 19 July 2022, the signing ceremony of the strategic cooperation agreement between Fosun International Limited and Industrial and Commercial Bank of China (ICBC) Shanghai Branch was held at ICBC Shanghai Branch. ICBC and Fosun will conduct in-depth cooperation in high technology, advanced manufacturing, bioph

On 19 July 2022, Guo Guangchang, Chairman of Fosun International, and his delegation visited FFT Produktionssysteme GmbH & Co. KG (hereinafter referred to as “FFT”), a subsidiary of Shanghai Easun Technology Co., Ltd. (“Easun Technology”), and unveiled for the opening of new FFT showroom in Fulda during their visit to Germany. Tristan Pfurr, CEO of FFT accompanied Guo Guangchang and his delegation to visit the new showroom, demonstrating the interaction and cooperation of multirobots, as well as FFT's proprietary technologies and application in related fields.

On 18 July 2022, Mr. Guo Guangchang, Chairman of Fosun International, and his delegation visited Yuyuan in Hamburg, and German lifestyle fashion brand Tom Tailor. He also met and had lunch with Ms. Carola Veit, President of the Hamburg Parliament. Mr. Marco Wiesner, Chief of Protocol of the Hamburg Parliament joined the meeting.This is the fir